- Exchange: NYSE MKT LLC
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Navidea Biopharmaceuticals Inc+ Add to Watchlist
NAVB:US2.5000 USD 0.0500 2.04%
As of 20:04:02 ET on 05/21/2013.
Company Profile for Navidea Biopharmaceuticals Inc (NAVB)
Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.
Navidea Biopharmaceuticals Inc
Key Executives for Navidea Biopharmaceuticals Inc (NAVB)
|Mark Jerome PykettChief Executive Officer||Thomas H Tulip "Thom"President/Chief Business Ofcr|
|Cornelia B ReiningerSenior VP/Chief Medical Officer||Brent L LarsonExec VP/CFO|
|Rodger A BrownVP:Regulatory Affairs|